14. Watanabe T., Hirata M., Yoshikawa Y., Nagafuchi Y., Toyoshima H., Watanabe T. Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. Lab Invest. 1985, vol. 53. no. 1. P. 80-90.
15. Hansson G.K., Seifert P.S., Olsson G., Bondjers G. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb. 1991. vol. 11. no. 3. P. 745-750.
16. Cybulsky M.I., Gimbrone M.A.Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991. vol. 251. no. 4995. P. 788-791.
17. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura T., Leonard E.J., Witztum J.L., Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A. 1991. vol. 88. no. 12. P. 5252-5256.
18. Rosenfeld M.E., Yla-Herttuala S., Lipton B.A., Ord V.A., Witztum J.L., Steinberg D. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol. 1992. vol. 140. no. 2. P. 291-300.
19. Duff G.L., Mc M.G. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. J Exp Med. 1949. vol. 89. no. 6. P. 611-630.
20. Sandesara P.B., Virani S.S., Fazio S., Shapiro M.D. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocr Rev. 2019. vol. 40. no. 2. P. 537-557.
21. Moore K.J., Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011. vol. 145. no. 3. P. 341-355.
22. Goldstein J.L., Kita T., Brown M.S. Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia. N Engl J Med. 1983. vol. 309. no. 5. P. 288-296.
23. Чаулин А.М., Александров А.Г., Александрова О.С., Дупляков Д.В. Роль пропротеин- конвертазы субтилизин/кексин типа 9 (pcsk9) в патофизиологии атеросклероза // Медицина в Кузбассе. 2019. Т. 18, № 4. С. 5-15.
24. Getz G.S., Reardon C.A. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol vol. 32. no. 5. P. 1104-1115.
25. Shiomi M., Koike T., Ito T. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins. Atherosclerosis vol. 231. no. 1. P.39-47.
26. Nair P. Brown and Goldstein: the cholesterol chronicles. Proc Natl Acad Sci U S A. 2013. vol. 110. no. 37. P. 14829-14832.
27. Taylor J.M., Fan J. Transgenic rabbit models for the study of atherosclerosis. Front Biosci. 1997. vol. 2. P. 298-308.
28. Roberts D.C.K., West C.E., Redgrave T.G., Smith J.B. Plasma cholesterol concentration in normal and cholesterol-fed rabbits. Atherosclerosis. 1974. vol. 19. no. 3. P. 369-380.
29. Tall A.R. Plasma cholesteryl ester transfer protein. J. Lipid Res. 1993. vol. 34. no. 8. P. 1255-1274.
30. Yan H., Niimi M., Matsuhisa F., Zhou H., Kitajima S., Chen Y., Wang C., Yang X., Yao J., Yang D., Zhang J., Murakami M., Nakajima K., Wang Y., Liu E., Liang J., Chen Y.E., Fan J. Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits. Arterioscler Thromb Vasc Biol. 2020: ATVBAHA120314368. https://pubmed.ncbi.nlm.nih.gov/32757647.
31. Yeang C., Cotter B., Tsimikas S. Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis. Cardiovasc Drugs Ther. 2016. vol. 30. no. 1. P. 75-85. Fan J., Araki M., Wu L., Challah M., Shimoyamada H., Lawn R.M., Kakuta H., Shikama H., Watanabe T. Assembly of lipoprotein (a) in transgenic rabbits expressing human apolipoprotein (a). Biochem Biophy Res Commun. 1999. vol. 255. no. 3. P. 639-644.
32. Ding Y., Wang Y., Zhu H., Fan J., Yu L., Liu G., Liu E. Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII. Transgenic Res. 2011. vol. 20. no. 4. P. 867-75.
33. Chiesa G., Hobbs H.H., Koschinsky M.L., Lawn R.M., Maika S.D., Hammer R.E. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J. Biol. Chem. 1992. vol. 267. no. 34. P. 24369-24374.
34. Takahashi S., Ito T., Zenimaru Y., Suzuki J., Miyamori I., Takahashi M., Takahashi M., Ishida T., Ishida T., Hirata K., Yamamoto T. T., Iwasaki T., Hattori H., Shiomi M. Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression. Biochem Biophys Res Commun. 2011. vol. 407. no. 4. P. 656-662.
35. Corti R., Osende J., Hutter R., Viles-Gonzalez J.F., Zafar U., Valdivieso C., Mizsei G., Fallon J.T., Fuster V., Badimon J.J. Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI. Atherosclerosis. 2007. vol. 190. no. 1. P. 106-113.
36. Wang Y.Y., Li H., Wang X.H., Yuan M., Li G.P. Probucol inhibits MMP-9 expression through regulating miR-497 in HUVECs and apoE knockout mice. Thromb Res. 2016. vol. 140. P. 51-58. doi:10.1016/j.thromres.2016.02.012
37. Badimon J.J., Badimon L., Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990. vol. 85. no. 4. P. 12341241.
38. Koike T., Kitajima S., Yu Y., Li Y., Nishijima K., Liu E., Sun H., Waqar A.B., Shibata N., Inoue T., Wang Y., Zhang B., Kobayashi J., Morimoto M., Saku K., Watanabe T., Fan J. Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia. Arterioscler Thromb. Vasc. Biol. 2010. vol. 29. no. 12. P. 2047-2053.
39. Fan J., Wang J., Bensadoun A., Lauer S.J., Dang Q., Mahley R.W., Taylor J.M. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 1994. vol. 91. no. 18. P. 8724-8728.
40. Wang C., Nishijima K., Kitajima S., Niimi M., Yan H., Chen Y., Ning B., Matsuhisa F., Liu E., Zhang J., Chen Y.E., Fan J. Increased Hepatic Expression of Endothelial Lipase Inhibits Cholesterol Diet-Induced Hypercholesterolemia and Atherosclerosis in Transgenic Rabbits. Arterioscler Thromb Vasc Biol. 2017. vol. 37. no. 7. P. 1282-1289.
41. Balastegui M.T., Ramos-Pla J.J., Ferrer-Puchol M.D. Cryoplasty versus angioplasty in the treatment of arterial restenosis in an experimental model of atherosclerosis in rabbits. Cryobiology. 2015;70(2):95-100.
42. Mushenkova N.V., Summerhill V.I., Silaeva Y.Y., Deykin A.V., Orekhov A.N. Modelling of atherosclerosis in genetically modified animals. Am. J. Transl. Res. 2019. vol. 11. no. 8. P. 46144633.
43. Thompson G.R. Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans. Atherosclerosis. 2018. vol. 276. P. 148-154.
44. Wacker B.K., Dronadula N., Bi L., Stamatikos A., Dichek D.A. Apo A-I (Apolipoprotein A- I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits. Arterioscler. Thromb. Vasc. Biol. 2018. vol. 38. no. 1. P. 206-217.
45. Wacker B.K., Bi L., Dichek D.A. In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium. J. Vis. Exp. 2018. vol. 135: 56982.